Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review

Abstract Background No literature review exists on Mycoplasma pneumoniae-associated mild encephalitis/encepharopathy with a reversible splenial lesion (MERS). Methods M.pneumoniae-associated MERS cases were searched till August 2016 using PubMed/Google for English/other-language publications and Ich...

Full description

Bibliographic Details
Main Authors: Norishi Ueda, Satoshi Minami, Manabu Akimoto
Format: Article
Language:English
Published: BMC 2016-11-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-016-1985-1
_version_ 1819003765720612864
author Norishi Ueda
Satoshi Minami
Manabu Akimoto
author_facet Norishi Ueda
Satoshi Minami
Manabu Akimoto
author_sort Norishi Ueda
collection DOAJ
description Abstract Background No literature review exists on Mycoplasma pneumoniae-associated mild encephalitis/encepharopathy with a reversible splenial lesion (MERS). Methods M.pneumoniae-associated MERS cases were searched till August 2016 using PubMed/Google for English/other-language publications and Ichushi ( http://www.jamas.or.jp/ ) for Japanese-language publications. Inclusion criteria were children fulfilling definition for encephalitis, M.pneumoniae infection, and neuroimaging showing hyperintensity in the splenium of the corpus callosum (SCC) alone (type I) or SCC/other brain areas (type II). Results We described two children with type I and II M.pneumoniae-associated MERS. Thirteen cases found by the search and our 2 cases were reviewed. Mean age, male/female ratio, duration of prodromal illness was 8.3 years, 1.5 and 3.5 days. The most common neurological symptom was drowsiness, followed by abnormal speech/behavior, ataxia, seizure, delirium, confusion, tremor, hallucination, irritability, muscle weakness, and facial nerve paralysis. Fever was the most common non-neurological symptom, followed by cough, headache, gastrointestinal symptoms, headache, lethargy and dizziness. Seizure and respiratory symptoms were less common. All were diagnosed for M.pneumoniae by serology. Cerebrospinal fluid (CSF) M.pneumoniae was undetectable by PCR in the 3 patients. Three patients were clarithromycin-resistant. Leukocytosis, positive C-reactive protein, hyponatremia, CSF pleocytosis and slow wave on electroencephalography frequently occurred. All except 2 were type I MERS. Neuroimaging abnormalities disappeared within 18 days in the majority of patients. All type I patients completely recovered within 19 days. Two type II patients developed neurological sequelae, which recovered 2 and 6 months after onset. Conclusions Prognosis of M.pneumoniae-associated MERS is excellent. Type II MERS may increase a risk of neurological sequelae.
first_indexed 2024-12-20T23:26:12Z
format Article
id doaj.art-b815af08e5384043b3275b8b05c15d72
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-20T23:26:12Z
publishDate 2016-11-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-b815af08e5384043b3275b8b05c15d722022-12-21T19:23:23ZengBMCBMC Infectious Diseases1471-23342016-11-0116111010.1186/s12879-016-1985-1Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature reviewNorishi Ueda0Satoshi Minami1Manabu Akimoto2Department of Pediatrics, Public Central Hospital of Matto IshikawaDepartment of Pediatrics, Public Central Hospital of Matto IshikawaDepartment of Radiology, Public Central Hospital of Matto IshikawaAbstract Background No literature review exists on Mycoplasma pneumoniae-associated mild encephalitis/encepharopathy with a reversible splenial lesion (MERS). Methods M.pneumoniae-associated MERS cases were searched till August 2016 using PubMed/Google for English/other-language publications and Ichushi ( http://www.jamas.or.jp/ ) for Japanese-language publications. Inclusion criteria were children fulfilling definition for encephalitis, M.pneumoniae infection, and neuroimaging showing hyperintensity in the splenium of the corpus callosum (SCC) alone (type I) or SCC/other brain areas (type II). Results We described two children with type I and II M.pneumoniae-associated MERS. Thirteen cases found by the search and our 2 cases were reviewed. Mean age, male/female ratio, duration of prodromal illness was 8.3 years, 1.5 and 3.5 days. The most common neurological symptom was drowsiness, followed by abnormal speech/behavior, ataxia, seizure, delirium, confusion, tremor, hallucination, irritability, muscle weakness, and facial nerve paralysis. Fever was the most common non-neurological symptom, followed by cough, headache, gastrointestinal symptoms, headache, lethargy and dizziness. Seizure and respiratory symptoms were less common. All were diagnosed for M.pneumoniae by serology. Cerebrospinal fluid (CSF) M.pneumoniae was undetectable by PCR in the 3 patients. Three patients were clarithromycin-resistant. Leukocytosis, positive C-reactive protein, hyponatremia, CSF pleocytosis and slow wave on electroencephalography frequently occurred. All except 2 were type I MERS. Neuroimaging abnormalities disappeared within 18 days in the majority of patients. All type I patients completely recovered within 19 days. Two type II patients developed neurological sequelae, which recovered 2 and 6 months after onset. Conclusions Prognosis of M.pneumoniae-associated MERS is excellent. Type II MERS may increase a risk of neurological sequelae.http://link.springer.com/article/10.1186/s12879-016-1985-1EncephalitisMERSNeuroimagingMycoplasma pneumoniaeSplenium of the corpus callosum
spellingShingle Norishi Ueda
Satoshi Minami
Manabu Akimoto
Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review
BMC Infectious Diseases
Encephalitis
MERS
Neuroimaging
Mycoplasma pneumoniae
Splenium of the corpus callosum
title Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review
title_full Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review
title_fullStr Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review
title_full_unstemmed Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review
title_short Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review
title_sort mycoplasma pneumoniae associated mild encephalitis encephalopathy with a reversible splenial lesion report of two pediatric cases and a comprehensive literature review
topic Encephalitis
MERS
Neuroimaging
Mycoplasma pneumoniae
Splenium of the corpus callosum
url http://link.springer.com/article/10.1186/s12879-016-1985-1
work_keys_str_mv AT norishiueda mycoplasmapneumoniaeassociatedmildencephalitisencephalopathywithareversiblespleniallesionreportoftwopediatriccasesandacomprehensiveliteraturereview
AT satoshiminami mycoplasmapneumoniaeassociatedmildencephalitisencephalopathywithareversiblespleniallesionreportoftwopediatriccasesandacomprehensiveliteraturereview
AT manabuakimoto mycoplasmapneumoniaeassociatedmildencephalitisencephalopathywithareversiblespleniallesionreportoftwopediatriccasesandacomprehensiveliteraturereview